OpenAI acquires Orchestra Bio

Summary

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

Lotu Radar provides attributed news summaries and links to the original publisher. Full reporting and copyright remain with the source.